Anti-Mouse/Human CD45R (B220) (Clone RA3-6B2) – DyLight® 488
Anti-Mouse/Human CD45R (B220) (Clone RA3-6B2) – DyLight® 488
Product No.: C1943
- -
- -
Clone RA3-6B2 Target CD45R Formats AvailableView All Product Type Monoclonal Antibody Alternate Names B220 Isotype IgG2a Applications FC , IHC FF |
- -
- -
Antibody DetailsProduct DetailsReactive Species Mouse/Human Host Species Rat Immunogen Abelson murine leukemia virus-induced pre-B tumor cells Product Concentration 0.2 mg/ml Formulation This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Storage and Handling This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze. Country of Origin USA Shipping Next Day 2-8°C Excitation Laser Blue Laser (493 nm) RRIDAB_2829025 Applications and Recommended Usage? Quality Tested by Leinco FC The suggested concentration for this RA3-6B2 antibody for staining cells in flow cytometry is ≤ 2.0 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application. Additional Applications Reported In Literature ? IHC-FF For specific conjugates of this clone, review literature for suggested application details. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone RA3-6B2 recognizes the B-cell determinant (Mr 220 kD) of the CD45 molecule. Background CD45 is a 180-240kD glycoprotein member of the protein tyrosine phosphatase (PTP) family known for its involvement in regulating a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. CD45 and its isoforms are vital regulators of T- and B-cell antigen receptor signaling. CD45 functions through its extracellular domain or through its cytoplasmic domain, and serves as a negative regulator of cytokine receptor signaling via JAK kinase supression. The large extracellular domain is highly glycosylated, and its multiple isoforms allow extensive variation in the structure of its side chains. CD45 isoforms show cell-type and differentiation-stage specific expression that can be used as markers that identify and distinguish between different types of immune cells. CD45R is an isoform of CD45 with a molecular weight of 220 kD. CD45R contains all three possible exons (A, B, and C); making it the longest protein generated from alternative splicing with a migration at 200 kD when isolated from T cells. Furthermore, B cells express CD45R with heavier glycosylation, bringing the molecular weight to 220 kD, hence the name B220. Notably, B220 expression is not only restricted to B cells and may also be expressed on activated T cells, on a subset of dendritic cells, and on other antigen-presenting cells. Additionally, activated and memory T lymphocytes express CD45RO which facilitates T cell activation. CD45RO lacks all three possible exons (A, B, and C), making it the shortest CD45 isoform. Antigen Distribution The CD45R antigen is present on mouse B-cells, B-cell precursors and lytically active subsets of lymphokine-activated killer cells (NK cells and non-MHC restricted CTL). Ligand/Receptor Galectin-1, CD2, CD3, CD4 PubMed UniProt.org Research Area Cell Biology . Immunology . Inhibitory Molecules . Neuroscience . Neuroscience Cell Markers References & Citations1. Coffman, B. et al. (1982) Immunological Rev. 69:5 2. Zuhair, K. et al. (1993) J. Immunol. 150:17 3. Asensi, V. et al. (1989) Immunology 68:204 Technical Protocols IHC FF Certificate of Analysis |
Formats Available
- -
- -
Prod No. | Description |
|---|---|
C259 | |
C260 | |
C261 | |
C351 | |
C262 | |
C1943 | |
C1945 | |
C1947 | |
C517 | |
C383 | |
C2844 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
